Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19. - Zhu B; Wei X; Narasimhan H; Qian W; Zhang R; Cheon IS; Wu Y; Li C; Jones RG; Kaplan MH; Vassallo RA; Braciale TJ; et al. (Science immunology, 2023)